This story originally ran on April 22.

AB Sciex and Thermo Fisher Scientific this week separately announced collaborations to expand research into disease areas such as cancer and develop workflows for clinical proteomics.

AB Sciex said it is working with the Samuel Lunenfeld Research Institute of Mt. Sinai Hospital in Toronto on a project that will use a new mass spectrometry platform being developed by the company. The focus of the proteomics project is to improve understanding of cancer, diabetes, and heart disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.